JAMA #Dermatology Highlights #melanoma #skincancer #eczema #dermatologia

In This Issue of JAMA Dermatology: Talimogene Laherparepvec–Ipilimumab for #Melanoma, Persistent Atopic #Dermatitis in Children, and more. https://t.co/a8d958av8X

— JAMA Dermatology (@JAMADerm) January 9, 2019